Value Sense
DXCM
DexCom, Inc. (DXCM)
Last Price$86.0(2.7%)
Market Cap$34.9B
LTM EPS
$1.47
EPS growth
42.2%
Ben Graham Fair Value
$117.0
Undervalued (Ben Graham formula)
36.1%
Stock quality
7/10
Great
DXCM
is 49.8% overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

DXCM Ben Graham Fair Value

Ben Graham Fair Value
Ben Graham Revised Fair Value

Ben Graham Fair Value Assumptions

as of Mar 10, 2025
EPS
$1.47
P/E Base for no-growth company
8.5x
EPS growth
42.2%
Average Yield of AAA Corporate Bonds
4.4%
Current Yield of AAA Corporate Bonds
5.1%
Last share price
$86.0
Ben Graham Fair Value (local)
$117.0
Ben Graham Fair Value
$117.0
36.1% undervalued

Ben Graham Fair Value Calculation

EPS
$1.47
x
(
P/E base for no-growth
8.5x
+
2
x
EPS growth
42.2%
)
x
Average AAA
Bond Yield
4.4%
/
Current AAA Bond Yield
5.1%
=
Ben Graham Fair Value
$117.0

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

DXCM EPS growth & Dividend Yield

Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
EPS growth
Dividend Yield

DXCM vs Peer Set: Ben Graham Fair Value Comparison

Ben Graham Fair Value
Ben Graham Revised Fair Value

GENERAL

BEN GRAHAM FAIR VALUE

FINANCIALS

Company name

Undervaluation / Overvaluation

Revenue growth

EPS growth

Net Income margin

DexCom, Inc. logo
DexCom, Inc.DXCM
36.1%
11.3%
(1.4%)
14.3%
Median Peer Set
4.1%
126.3%
11.8%
Koninklijke Philips N.V. logo
Koninklijke Philips N.V.PHG
1,189.9%
(0.8%)
118.1%
(3.9%)
STERIS plc logo
STERIS plcSTE
420.7%
3.6%
257.9%
7.4%
Align Technology, Inc. logo
Align Technology, Inc.ALGN
256.6%
3.4%
26.0%
11.5%
Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc.ZBH
253.6%
6.5%
253.2%
13.8%
Stryker Corporation logo
Stryker CorporationSYK
159.6%
10.2%
(5.8%)
13.2%
Boston Scientific Corporation logo
Boston Scientific CorporationBSX
82.4%
17.6%
16.7%
11.1%
Medtronic plc logo
Medtronic plcMDT
(9.9%)
3.6%
(2.1%)
11.4%
Insulet Corporation logo
Insulet CorporationPODD
(51.8%)
30.0%
4,364.6%
12.2%
Abbott Laboratories logo
Abbott LaboratoriesABT
(375.9%)
4.6%
134.5%
31.9%
Edwards Lifesciences Corporation logo
Edwards Lifesciences CorporationEW
(1,112.7%)
(9.4%)
202.2%
76.7%

Explore more intrinsic value tools hub for DXCM

Peter Lynch Fair Value
Reverse DCF
Earnings growth model
Earnings Power Value
Discount rate
Relative Value
Intrinsic Value
Margin of safety
DCF value calculator
Peter Lynch charts

FAQ

What is DexCom, Inc.'s fair value according to the Ben Graham formula?

As of Dec 31, 2024, DexCom, Inc.'s fair value using the Ben Graham formula is $117.0 per share. This is calculated using Ben Graham formula, where EPS is $1.5 and BVPS (Book Value Per Share) is $5.3. The current price of $86.0 suggests DexCom, Inc. may be overvalued by this conservative metric.

What is DexCom, Inc. earnings per share (EPS)?

DexCom, Inc. earnings per share (EPS) for the twelve months ending Dec 31, 2024, was $1.5, a 42.2% growth year-over-year.

What is DexCom, Inc.'s margin of safety based on the Ben Graham analysis?

DexCom, Inc.'s margin of safety is positive 36.1%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.